Daniel Grunder
Chairman at GoodWind Holding GmbH
Profile
Daniel Grunder is associated with GoodWind Holding GmbH, Welle Holding AG + Co. KG, and TXP Pharma AG (Switzerland) as a Chairman, Director, and Director respectively.
Daniel Grunder active positions
Companies | Position | Start |
---|---|---|
Welle Holding AG + Co. KG
Welle Holding AG + Co. KG Home FurnishingsConsumer Durables Welle Holding AG + Co. KG manufactures wooden and upholstered furniture. It provides furniture for kitchen, babies, children and teenagers. The company is headquartered in Paderborn, Germany. | Director/Board Member | - |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Director/Board Member | - |
GoodWind Holding GmbH
GoodWind Holding GmbH Financial ConglomeratesFinance GoodWind Holding GmbH is a Swiss company that specializes in the acquisition, management, and sale of securities and similar assets. The private company is based in Baar, Switzerland. The company also handle financing and fiduciary transactions. | Chairman | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Welle Holding AG + Co. KG
Welle Holding AG + Co. KG Home FurnishingsConsumer Durables Welle Holding AG + Co. KG manufactures wooden and upholstered furniture. It provides furniture for kitchen, babies, children and teenagers. The company is headquartered in Paderborn, Germany. | Consumer Durables |
GoodWind Holding GmbH
GoodWind Holding GmbH Financial ConglomeratesFinance GoodWind Holding GmbH is a Swiss company that specializes in the acquisition, management, and sale of securities and similar assets. The private company is based in Baar, Switzerland. The company also handle financing and fiduciary transactions. | Finance |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Health Technology |
- Stock Market
- Insiders
- Daniel Grunder